STROKE OUTCOMES IN NON-DIABETIC, DENOVO DIABETIC AND DIABETIC INDIAN PATIENTS MEASURED BY MODIFIED RANKIN SCALE: AN OBSERVATIONAL STUDY
DOI:
https://doi.org/10.22159/ijpps.2017v9i8.18378Keywords:
Stroke, Hyperglycemia, Denovo diabetes, Modified Rankin scale, OutcomesAbstract
Objective: Hyperglycemia is a known risk factor which adversely impacts the outcomes in stroke patients compared to patients with normal blood glucose levels. Patients suffering from an acute stroke who are previously nonhyperglycemic may show elevated blood glucose levels. The present study was designed to measure the outcomes in denovo diabetic and diabetic stroke patients compared to nondiabetics.
Methods: A prospective observational study over a period of 6 mo, in which 103 patients were divided into three cohorts based on their blood glucose levels (nondiabetic, denovo diabetic and diabetics). The modified Rankin scale (mRS) score was calculated at in-hospital admission and discharge in these three cohorts. The initial and final scores were correlated and mean differences with respect to outcomes between all the three cohorts was calculated.
Results: The mean mRS at the time of hospital admission in diabetics and nondiabetics was 3.6±0.81 and 3.3±0.78 which decreased to 2.8±0.95 and 2.9±0.83 respectively at the time of discharge. The mean mRS score in denovo diabetic stroke patients during in-hospital admission was 4±0.81 which was calculated as 3.7±0.85 at the time of discharge. The mean difference in mRS score in diabetics vs non-diabetics was found to be 0.73±0.8 (p =<0.001). The mean difference in mRS score of denovo diabetics vs non-diabetics and denovo diabetics vs diabetics was 0.30±0.63 and 0.38±0.61 respectively (p = 0.1).
Conclusion: Results of these observational study in Indian patients, highlights the need for controlling hyperglycemia in stroke patients to improve outcomes and to prevent mortality arising out of acute stroke attacks.
Downloads
References
Siddiqui AH, Natarajan SK, Hopkins LN, Levy EI. Carotid artery stenting for primary and secondary stroke prevention. World Neurosurg 2011;76:S40-59.
WHO. MONICA Project Investigators. The World Health Organization MONICA Project (Monitoring trends and determinants in cardiovascular disease). J Clin Epidemiol 1988;41:105-14.
Mukherjee D, Patil CG. Epidemiology and Global burden of stroke. World Neurosurg 2011;76:S85-90.
Mackay J, Mensah AG. The Atlas of Heart Disease and Stroke, Deaths from a stroke; WHO-CDC. Available from: http://www.who.int/cardiovascular_diseases/resources/atlas/en/] [Last accessed on 10 Mar 2015]
Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics-2015 Update. A report from the american heart association. Circulation 2015;131:e29-e322.
Pandian JD, Sudhan P. Stroke epidemiology and stroke care services in India. J Stroke 2013;15:128–34.
Nagaraja D, Gururaj G, Girish N, Panda S, Roy AK, Sarma GRK, et al. Feasibility study of stroke surveillance: data from Bangalore, India. Indian J Med Res 2009;130:396-403.
Karatepe AG, Gunaydin R, Kaya T, Turkmen G. Comorbidity in patients after stroke: impact on functional outcome. J Rehabil Med 2008;40:831–5.
O’Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, et al. Risk factors for ischemic and intracerebral haemorrhagic stroke in 22 countries (the INTER STROKE study): a case-control study. Lancet 2010;376:112–23.
Jia Q, Zhao X, Wang C, Wang Y, Yan Y, Li H, et al. Diabetes and poor outcomes within 6 mo after acute ischemic stroke: the China National Stroke Registry. Stroke 2011;42:2758-62.
Poppe AY, Majumdar SR, Jeerakathil T, Ghali W, Buchan AM, Hill MD. Admission hyperglycemia predicts a worse outcome in stroke patients treated with intravenous thrombolysis. Diabetes Care 2009;32:617–22.
Diener HC, Lees KR, Lyden P, Grotta J, Davalos A, Davis SM, et al. NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II trials. Stroke 2008;39:1751–8.
Stead LG, Gilmore RM, Bellolio MF, Mishra S, Bhagra A, Vaidyanathan L, et al. Hyperglycemia as an independent predictor of worse outcome in non-diabetic patients presenting with acute ischemic stroke. Neurocrit Care 2009;10:181-6.
Tanaka R, Ueno Y, Miyamoto N, Yamashiro K, Tanaka Y, Shimura H, et al. Impact of diabetes and prediabetes on the short term prognosis in patients with acute ischemic stroke. J Neurol Sci 2013;332:45-50.
Jia Q, Liu G, Zheng H, Zhao X, Wang C, Wang Y, et al. Impaired glucose regulation predicted 1 y mortality of chinese patients with ischemic stroke: data from abnormal glucose regulation in patients with an acute stroke across China. Stroke 2014;45:1498-500.
Buysschaert M, Bergman M. Definition of pre diabetes. Med Clin North Am 2011;95:289–97.
Fonville S, Zandbergen AA, Vermeer SE, Dippel DW, Koudstaal PJ, den Hertog HM, et al. Prevalence of prediabetes and newly diagnosed diabetes in patients with a transient ischemic attack or stroke. Cerebrovasc Dis 2013;36:283-9.
Osei E, Fonville S, Zandbergen AA, Koudstaal PJ, Dippel DW, den Hertog HM. Glucose in prediabetic and diabetic range and outcome after stroke. Acta Neurol Scand 2017;135:170-5.
Siemkowicz E, Hansen AJ. Brain extracellular ion composition and EEG activity following 10 min ischemia in normo-and hyperglycaemic rats. Stroke 1981;12:236-40.
Robbins NM, Swanson RA. Opposing effects of glucose on stroke and reperfusion injury: acidosis, oxidative stress, and energy metabolism. Stroke 2014;45:1881-6.
Luitse MJ, Biessels GJ, Rutten GE, Kappelle LJ. Diabetes, hyperglycaemia, and acute ischaemic stroke. Lancet Neurol 2012;11:261-71.
Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001; 32:2426-32.
Published
How to Cite
Issue
Section
